Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Recurrence 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 516Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 341Paclitaxel 336Oxaliplatin 335Gemcitabine 323Docetaxel 316Fluorouracil 289Drug Therapy 276apatinib 247Bevacizumab 247camrelizumab 219Etoposide 201Irinotecan 181Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145Blood Specimen Collection 140anlotinib 139Pemetrexed 138Cytarabine 138toripalimab 134Surgical Procedures, Operative 131Radiosurgery 130S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Thymopentin × Clear all
NCT00460681 2007-10-31

Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma

Fudan University

Phase 3 Unknown
220 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡